相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Targeting triple negative breast cancer: Is p53 the answer?
Natalie Turner et al.
CANCER TREATMENT REVIEWS (2013)
A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer
Adisorn Ratanaphan
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η6-p-phenylethacrynate)Cl2(pta)]
Korawan Chakree et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
DNA-binding properties of ruthenium(II) complexes with the bidentate ligand 5-chloro-2-(phenylazo)pyridine
Adisorn Ratanaphan et al.
TRANSITION METAL CHEMISTRY (2012)
BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer
A. Font et al.
ANNALS OF ONCOLOGY (2011)
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs
Apichart Atipairin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Synthesis, cellular uptake, apopotosis, cytotoxicity, cell cycle arrest, interaction with DNA and antioxidant activity of ruthenium(II) complexes
Hong-Liang Huang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature
Apichart Atipairin et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis
Soumya Chatterjee et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
Laura N. Burga et al.
BREAST CANCER RESEARCH (2011)
Cisplatin-gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients
Nebu Koshy et al.
BREAST (2010)
Identification of Breast Tumor Mutations in BRCA1 That Abolish Its Function in Homologous DNA Recombination
Derek J. R. Ransburgh et al.
CANCER RESEARCH (2010)
Targeting DNA repair in breast cancer: A clinical and translational update
Eitan Amir et al.
CANCER TREATMENT REVIEWS (2010)
In vitro Ruthenation of Human Breast Cancer Suppressor Gene 1 (BRCA1) by the Antimetastasis Compound RAPTA-C and Its Analogue CarboRAPTA-C
Adisorn Ratanaphan et al.
CHEMISTRY & BIODIVERSITY (2010)
Cisplatin Affects the Conformation of Apo Form, not Holo Form, of BRCA1 RING Finger Domain and Confers Thermal Stability
Apichart Atipairin et al.
CHEMISTRY & BIODIVERSITY (2010)
In Vitro Cytotoxicity, Apoptosis, DNA-Binding, and Antioxidant Activity Studies of Ruthenium (II) Complexes
Hong-Liang Huang et al.
DNA AND CELL BIOLOGY (2010)
Ruthenium Polypyridyl Complexes That Induce Mitochondria-Mediated Apoptosis in Cancer Cells
Tianfeng Chen et al.
INORGANIC CHEMISTRY (2010)
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
Daniel P. Silver et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Nuclear Permeable Ruthenium(II)β-Carboline Complexes Induce Autophagy To Antagonize Mitochondrial-Mediated Apoptosis
Caiping Tan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Traffic Control for BRCA1
William D. Foulkes
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Prognostic Value of BRCA1 mRNA Expression Levels Following Neoadjuvant Chemotherapy in Breast Cancer
Mireia Margeli et al.
PLOS ONE (2010)
Stability of folding structure of Zic zinc finger proteins
Kumiko Sakai-Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
Pierfrancesco Tassone et al.
CANCER BIOLOGY & THERAPY (2009)
Targeting DNA repair pathways: A novel approach to reduce cancer therapeutic resistance
Yongjian Zhu et al.
CANCER TREATMENT REVIEWS (2009)
Targeting the DNA damage response for cancer therapy
Simon N. Powell et al.
DNA REPAIR (2009)
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
Judith Hugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Platinum-based chemotherapy in triple-negative breast cancer
B. Sirohi et al.
ANNALS OF ONCOLOGY (2008)
CD spectra show the relational style between Zic-, Gli-, Glis-zinc finger protein and DNA
Kumiko Sakai-Kato et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
Elizabeth M. Swisher et al.
CANCER RESEARCH (2008)
DNA damage repair and response proteins as targets for cancer therapy
Howard B. Lieberman
CURRENT MEDICINAL CHEMISTRY (2008)
The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways
Soumya Chatterjee et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2008)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Rapid Recruitment of BRCA1 to DNA Double-Strand Breaks Is Dependent on Its Association with Ku80
Leizhen Wei et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
DNA repair pathways as targets for cancer therapy
Thomas Helleday et al.
NATURE REVIEWS CANCER (2008)
Methods to explore cellular uptake of ruthenium complexes
Cindy A. Puckett et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Triple-negative breast cancer: therapeutic options
Susan Cleator et al.
LANCET ONCOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Inhibition of B16 melanoma metastases with the ruthenium complex imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate and down-regulation of tumor cell invasion
B Gava et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Using circular dichroism spectra to estimate protein secondary structure
Norma J. Greenfield
NATURE PROTOCOLS (2006)
In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin
A Ratanaphan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2005)
Redox-active antineoplastic ruthenium complexes with indazole: Correlation of in vitro potency and reduction potential
MA Jakupec et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
S Kapitza et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
The role of BRCA1 in the cellular response to chemotherapy
RD Kennedy et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
A phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent
JM Rademaker-Lakhai et al.
CLINICAL CANCER RESEARCH (2004)
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
M Taron et al.
HUMAN MOLECULAR GENETICS (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
H Ruffner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Epidermal growth factor-induced nuclear factor κB activation:: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells
DK Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)